LifeStance Health Finalizes Secondary Offering at Premium Price, Repurchases 6 Million Shares
LFST has more than doubled off its 52-week low of $3.74 on elevated volume (6.9× avg).
Summary
LifeStance Health Group finalized a secondary offering of 35 million shares at a premium price of $8.15 per share, while simultaneously repurchasing 6 million shares for $48.12 million, leading to a net reduction in outstanding shares.
Key Events · Financing and Capital Events · LFST
-
Secondary Offering Finalized
Selling stockholders are offering 35,000,000 shares of common stock at a public offering price of $8.15 per share, totaling $285.25 million. The company will not receive any proceeds from these sales.
-
Company Repurchases Shares
LifeStance Health Group will repurchase 6,000,000 shares from the underwriter for an aggregate value of $48.12 million, funded by cash on hand. These shares will be retired, reducing the total outstanding share count.
-
Premium Pricing
The offering price of $8.15 per share is a 6.67% premium compared to the current stock price of $7.64, signaling strong market demand and investor confidence.
-
Anti-Dilutive Impact
The company's repurchase of 6 million shares will result in a net reduction of approximately 1.55% in the total outstanding shares, making the overall transaction anti-dilutive.
Analysis · LFST · Industrial Applications And Services
LifeStance Health Group has finalized the terms of a secondary public offering where selling stockholders are selling 35 million shares at $8.15 per share. This pricing represents a significant 6.67% premium over the current market price of $7.64, indicating strong institutional demand and market confidence, especially following the company's recent robust Q1 2026 earnings report. Crucially, the company will repurchase 6 million of these shares for $48.12 million using cash on hand, resulting in a net reduction of 1.55% in total outstanding shares. This anti-dilutive action, combined with the premium pricing, transforms what would typically be a negative secondary offering into a highly positive capital event, demonstrating management's confidence and commitment to shareholder value.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 52.1% of the 217 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.69%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LFST was trading at $7.64 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3B. The 52-week trading range was $3.74 to $8.89. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.